Compare Diageo plc (DEO) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diageo plc vs Novavax Inc — how do they compare? Diageo plc trades at $94.44 (market cap $53.05B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Diageo plc is far larger — about 40.5× Novavax Inc's market cap, and Diageo plc pays a 3.5% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| DEO | NVAX | |
|---|---|---|
Market Cap | $53.05B | $1.31B |
Sector | Technology | Health |
52-Week High | $115.33 | $11.19 |
52-Week Low | $72.47 | $6.22 |
Enterprise Value | $72.54B | $889.30M |
Dividend Yield | 3.5% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
